|
1-(2-溴苯基)萘
|
B290453-1g
|
≥98%(HPLC) |
18937-92-3 |
1g
|
¥ 71.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
7-溴-9,9-二乙基-N,N-二苯基-9H-芴-2-胺
|
B290448-1g
|
≥98%(HPLC) |
202831-64-9 |
1g
|
¥ 1904.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(双(4-溴苯基)氨基)苯甲醛
|
B290416-1g
|
≥98%(HPLC) |
1469780-16-2 |
1g
|
¥ 3173.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-溴-N,N-二对甲苯基苯胺
|
B290412-1g
|
≥98% |
845526-91-2 |
1g
|
¥ 138.9
|
现货 |
|
0 |
阿拉丁 |
|
2-溴-6-(溴甲基)萘
|
B290407-1g
|
≥98%(HPLC) |
305798-02-1 |
1g
|
¥ 549.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-溴-7-叔丁基py
|
B290405-10g
|
≥95%(HPLC) |
78751-74-3 |
10g
|
¥ 12826.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3,6-双(5-溴噻吩-2-基)-2,5-二辛基吡咯并[3,4-c]吡咯-1,4(2H,5H)-二酮
|
B290401-1g
|
≥98%(NMR) |
1057401-13-4 |
1g
|
¥ 1482.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3,6-双(5-溴噻吩-2-基)-2,5-二己基吡咯并[3,4-c]吡咯-1,4(2H,5H)-二酮
|
B290400-10g
|
≥98%(NMR) |
1214906-01-0 |
10g
|
¥ 26966.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-溴5'-己基-2,2'-联噻吩
|
B290399-10g
|
≥95%(HPLC) |
655249-04-0 |
10g
|
¥ 6345.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5,5'-双(5-溴噻吩-2-基)-4,4'-二己基-2,2'-联噻唑
|
B290396-1g
|
≥98%(HPLC) |
853722-91-5 |
1g
|
¥ 7750.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3,6-双(5-溴噻吩-2-基)-2,5-双(2-乙基己基)吡咯并[3,4-c]吡咯-1,4(2H,5H)-二酮
|
B290394-1g
|
≥98%(HPLC) |
1000623-95-9 |
1g
|
¥ 583.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
硼亚2,3-萘酞菁氯化物
|
B290358-1g
|
升华级, ≥99% |
142710-56-3 |
1g
|
¥ 21414.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
氯化亚酞菁硼
|
B290356-1g
|
升华级, ≥99% |
36530-06-0 |
1g
|
¥ 5711.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,9-双(1-丁基戊基)-蒽[2,1,9-def:6,5,10-d'e'f']二异喹啉-1,3,8,10(2H,9H)-四元
|
B290328-1g
|
≥99%(NMR) |
110613-98-4 |
1g
|
¥ 9200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Bisbenzimidazo [2,1-a:1',2-b'] anthra [2,1,9-def:6,5,10-d'e'f'] diisoguinoline-10,21-dione,带有顺式异构体
|
B290315-1g
|
升华级 |
55034-79-2 |
1g
|
¥ 7297.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(5-(苯并呋喃-2-基)噻吩-2-基)-2,5-双(2-乙基己基)吡咯并[3,4-c]吡咯-1,4(2H,5H) - 二酮
|
B290254-1g
|
≥99%(NMR) |
1241836-03-2 |
1g
|
¥ 25221.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
α,ω-双(联苯基-4-基)-对噻吩
|
B290252-1g
|
升华级 |
256342-43-5 |
1g
|
¥ 7773.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,7-双[2-(2,2'-联吡啶-6-基)-1,3,4-恶二唑-5-基] -9,9-二甲基芴
|
B290217-1g
|
升华级, ≥99%(HPLC) |
1174006-45-1 |
1g
|
¥ 6187.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6,6'-双[5-(联苯-4-基)-1,3,4-恶二唑-2-基] -2,2'-联吡啶基
|
B290214-1g
|
升华级, ≥99%(HPLC) |
1219827-28-7 |
1g
|
¥ 4125.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,3-双[2-(2,2'-联吡啶-6-基)-1,3,4-恶二唑-5-基]苯
|
B290213-1g
|
升华级, ≥99%(HPLC) |
866117-19-3 |
1g
|
¥ 8407.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-(7-(9,9'-双色烯-10-基)-9,9-二辛基-9H-芴-2-基)芘
|
B290050-1g
|
≥99%(HPLC) |
1258522-34-7 |
1g
|
¥ 7614.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-(7-(9,9'-双色烯-10-基)-9,9-二己基-9H-氟-2-基)芘
|
B290033-1g
|
≥99%(HPLC) |
1705571-71-6 |
1g
|
¥ 6821.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-(7-(9,9'-双色烯-10-基)-9,9-二甲基-9H-芴-2-基)芘
|
B290032-1g
|
升华级, ≥99%(HPLC) |
1705571-70-5 |
1g
|
¥ 7138.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BMS 493,泛RAR反向激动剂
|
B288943-50mg
|
Moligand™, ≥98%(HPLC) |
215030-90-3 |
50mg
|
¥ 5499.9
|
期货,请咨询 |
|
0 |
阿拉丁 |